Innovation Pharmaceuticals Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IPIX research report →
Companywww.ipharminc.com
Innovation Pharmaceuticals Inc. , a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19.
- CEO
- Leo Ehrlich
- IPO
- 2007
- Employees
- 4
- HQ
- Wakefield, MA, US
Price Chart
Valuation
- Market Cap
- $155.50K
- P/E
- -0.05
- P/S
- 0.00
- P/B
- 0.07
- EV/EBITDA
- 0.23
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -93.60%
- ROIC
- -112.55%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-3,168,000 · 55.01%
- EPS
- $-0.01 · 55.00%
- Op Income
- $-3,111,000
- FCF YoY
- 65.94%
Performance & Tape
- 52W High
- $0.05
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.49
- Avg Volume
- 124.42K
Get TickerSpark's AI analysis on IPIX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 30, 22 | EHRLICH LEO | other | 11,307,527 |
| Oct 10, 21 | Harness Jane A. | other | 500,000 |
| Sep 11, 20 | Harness Jane A. | other | 58,394 |
| Sep 1, 19 | Harness Jane A. | other | 58,394 |
| Sep 11, 20 | Harness Jane A. | other | 21,606 |
| Sep 1, 19 | Harness Jane A. | other | 172,987 |
| Sep 11, 20 | Harness Jane A. | other | 172,987 |
| Sep 1, 17 | Harness Jane A. | other | 1,000 |
| Oct 10, 21 | Schechter Barry A | other | 1,000,000 |
| Feb 23, 20 | Schechter Barry A | other | 500,000 |
Our IPIX Coverage
We haven't published any research on IPIX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IPIX Report →